Research & Development Solutions — Revenue
IQVIA Research & Development Solutions — Revenue increased by 2.7% to $2.40B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.0%, from $2.10B to $2.40B. Over 4 years (FY 2021 to FY 2025), Research & Development Solutions — Revenue shows an upward trend with a 4.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong demand for outsourced clinical trial services and successful project execution, while a decrease may signal pricing pressure or a slowdown in pharmaceutical R&D spending.
Detailed definition
Represents the total gross income generated by the contract research organization segment through the provision of clini...
Peer comparison
Comparable to service revenue metrics in other global Contract Research Organizations (CROs).
iqv_segment_research_development_solutions_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.89B | $1.85B | $1.94B | $1.93B | $1.95B | $1.98B | $2.06B | $2.03B | $2.10B | $2.12B | $2.15B | $2.10B | $2.15B | $2.16B | $2.12B | $2.10B | $2.20B | $2.26B | $2.33B | $2.40B |
| QoQ Change | — | -2.0% | +4.9% | -0.5% | +0.8% | +1.5% | +4.0% | -1.6% | +3.5% | +1.2% | +1.4% | -2.6% | +2.5% | +0.7% | -1.8% | -1.0% | +4.7% | +2.7% | +3.2% | +2.7% |
| YoY Change | — | — | — | — | +3.1% | +6.8% | +5.9% | +4.8% | +7.5% | +7.2% | +4.5% | +3.4% | +2.4% | +1.9% | -1.3% | +0.3% | +2.5% | +4.5% | +9.9% | +14.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IQVIA's research & development solutions — revenue?
- IQVIA (IQV) reported research & development solutions — revenue of $2.40B in Q1 2026.
- How has IQVIA's research & development solutions — revenue changed year-over-year?
- IQVIA's research & development solutions — revenue increased by 14.0% year-over-year, from $2.10B to $2.40B.
- What is the long-term trend for IQVIA's research & development solutions — revenue?
- Over 4 years (2021 to 2025), IQVIA's research & development solutions — revenue has grown at a 4.2% compound annual growth rate (CAGR), from $7.56B to $8.90B.
- What does research & development solutions — revenue mean?
- The total sales generated by the clinical research and drug development services division.